Literature DB >> 10888303

Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.

T Zhu1, X Z Chen, A Steel, M A Hediger, D E Smith.   

Abstract

PURPOSE: To examine the mechanism of inhibition of glycylsarcosine (GlySar) transport by quinapril and enalapril, and whether or not angiotensin converting enzyme (ACE) inhibitors are transported by PEPT2 as well as by PEPT1.
METHODS: Xenopus laevis oocytes were cRNA-injected with rat PEPT1 or PEPT2 and the transport kinetics of radiolabeled GlySar were studied in the absence and presence of quinapril and enalapril. The two-microelectrode voltage-clamp technique was also performed to probe the electrogenic uptake of captopril, quinapril and enalapril.
RESULTS: Kinetic analyses demonstrated that quinapril inhibited the uptake of GlySar in a noncompetitive manner in Xenopus oocytes injected with PEPT1 or PEPT2 (Ki = 0.8 or 0.4 mM, respectively). In contrast, a competitive interaction was observed between GlySar and enalapril (Ki = 10.8 mM for PEPT1 or 4.3 mM for PEPT2). Most significantly, captopril and enalapril, but not quinapril, induced inwardly-directed currents in both PEPT1- and PEPT2-expressed oocytes.
CONCLUSIONS: These results are unique in providing direct evidence for the substrate recognition and transport of some ACE inhibitors by the high- and low-affinity oligopeptide transporters. Our findings point to differences between PEPT1 and PEPT2 in their affinity to, rather than in their specificity for, ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888303     DOI: 10.1023/a:1007556630189

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Isolation and characterization of circulating low molecular weight peptides in steer, sheep and rat portal and peripheral blood.

Authors:  C J Seal; D S Parker
Journal:  Comp Biochem Physiol B       Date:  1991

2.  Expression cloning of a mammalian proton-coupled oligopeptide transporter.

Authors:  Y J Fei; Y Kanai; S Nussberger; V Ganapathy; F H Leibach; M F Romero; S K Singh; W F Boron; M A Hediger
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

3.  Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter.

Authors:  C S Temple; C A Boyd
Journal:  Biochim Biophys Acta       Date:  1998-08-14

4.  Cloning and functional expression of a brain peptide/histidine transporter.

Authors:  T Yamashita; S Shimada; W Guo; K Sato; E Kohmura; T Hayakawa; T Takagi; M Tohyama
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

5.  Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors.

Authors:  M Boll; D Markovich; W M Weber; H Korte; H Daniel; H Murer
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

6.  Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization.

Authors:  R Liang; Y J Fei; P D Prasad; S Ramamoorthy; H Han; T L Yang-Feng; M A Hediger; V Ganapathy; F H Leibach
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

7.  Characterization of a rat Na+-dicarboxylate cotransporter.

Authors:  X Z Chen; C Shayakul; U V Berger; W Tian; M A Hediger
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

8.  Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter.

Authors:  M Boll; M Herget; M Wagener; W M Weber; D Markovich; J Biber; W Clauss; H Murer; H Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter.

Authors:  K Miyamoto; T Shiraga; K Morita; H Yamamoto; H Haga; Y Taketani; I Tamai; Y Sai; A Tsuji; E Takeda
Journal:  Biochim Biophys Acta       Date:  1996-02-07

10.  Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2.

Authors:  X Z Chen; T Zhu; D E Smith; M A Hediger
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  15 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

2.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.

Authors:  Monica Sala-Rabanal; Donald D F Loo; Bruce A Hirayama; Eric Turk; Ernest M Wright
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

4.  Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.

Authors:  A Sivadas; M Z Salleh; L K Teh; V Scaria
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

Review 5.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

Review 6.  Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.

Authors:  Susan M Abdel-Rahman; Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

7.  Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.

Authors:  Feifeng Song; Yongjun Hu; Huidi Jiang; David E Smith
Journal:  Drug Metab Dispos       Date:  2016-11-11       Impact factor: 3.922

8.  Evolution of an amino acid based prodrug approach: stay tuned.

Authors:  Ivan S Krylov; Boris A Kashemirov; John M Hilfinger; Charles E McKenna
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

9.  Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.

Authors:  C U Nielsen; S Frølund; S Abdulhadi; H Sari; L Langthaler; M K Nøhr; M A Kall; B Brodin; R Holm
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

10.  Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes.

Authors:  Kaixun Li; Liya Xu; Ashutosh A Kulkarni; Daya I Perkins; Ian S Haworth; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.